Mehmet Oz, President Trump’s nominee to lead the Centers for Medicare and Medicaid Services, advocated for the use of artificial intelligence to counter inappropriate denials of service by insurers, at his Senate confirmation hearing which touched on pending lawsuits against insurance companies using AI to process claims.
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
Home
Top Stories
NIH Document: Mass Cancellation Of Grants Not Related To Executive Orders
A 14-page list of National Institutes of Health grants terminated by the Trump administration says the terminations were not related to any executive order, despite the targeting of areas like LGBT health care and health equity that President Donald Trump’s executive orders have made it clear agencies should deprioritize.
NIH Pulls Grant Funding From Research On HIV Prevention
Transition 2025
Burgess Floated As New Contender For Head Of CDC
President Donald Trump reportedly is considering former member of Congress Michael Burgess, a longtime GOP health care leader and an obstetrician-gynecologist, as the next head of the Centers for Disease Control and Prevention (CDC), while the anti-vaccine group founded by HHS Secretary Robert F. Kennedy Jr. is pushing Joseph Ladapo, the controversial Florida surgeon general, for the position.
April ACIP Meeting May Offer Glimpse Of Advisers’ Role In Vaccine Policy
DOGE Hiring At HHS Raises Legal Questions, Former HHS General Counsel Says
Latest News
Former Indiana Rep. Larry Bucshon, now a senior advisor with Holland & Knight, is the latest Republican to publicly suggest that despite the GOP’s opposition to the enhanced Affordable Care Act tax credits set to expire at the end the year, he expects Congress will ultimately extend a revamped version of the APTCs.
Health care stakeholders are watching to see how the Trump administration’s move last month to ratchet back the power of administrative law judges by having them report to the Department of Justice might shift administrative claims and appeals resolutions, as well as fines, under CMS and FDA.
Major health care law firms are among the targets of a letter from the U.S. Equal Employment Opportunity Commission indicating they may be investigated for their use of diversity, equity and inclusion (DEI) employment practices.
FDA is launching an initiative it’s calling “Operation Stork Speed” that will aim to boost infant formula availability and will include a comprehensive review of ingredients in formula products and new research on the health impacts of formula consumption, the agency announced Tuesday (March 18).